Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation

Circulation

Volumn 133, Issue 21, 2016, Pages 2050-2065

  Ballantyne, Margaret D ^a,b   Pinel, Karine ^b   Dakin, Rachel ^a   Vesey, Alex T ^b   Diver, Louise ^a   Mackenzie, Ruth ^a   Garcia, Raquel ^a   Welsh, Paul ^a   Sattar, Naveed ^a   Hamilton, Graham ^c   Joshi, Nikhil ^b   Dweck, Marc R ^b   Miano, Joseph M ^d   McBride, Martin W ^a   Newby, David E ^b   McDonald, Robert A ^a,b   Baker, Andrew H ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

atherosclerosis; cell proliferation; microRNAs; plasma protein, human; RNA, untranslated

Indexed keywords

INTERLEUKIN 1ALPHA; LONG UNTRANSLATED RNA; PLATELET DERIVED GROWTH FACTOR; SMALL INTERFERING RNA; SMOOTH MUSCLE ENRICHED LONG NONCODING RNA; UNCLASSIFIED DRUG; CAENORHABDITIS ELEGANS PROTEIN;

ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY PLAQUE; CELL CYCLE; CELL PROLIFERATION; GENE; GENE EXPRESSION; GENE LOCATION; HAS2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE CELL; CELL CULTURE; CYTOLOGY; GENE SILENCING; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

CAENORHABDITIS ELEGANS PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RNA, LONG NONCODING; SAPHENOUS VEIN;

EID: 84963649305     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.021019     Document Type: Article

References (59)

1. Marx SO, Totary-Jain H, Marks AR, Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011 4 104 111. doi: 10.1161/CIRCINTERVENTIONS.110.957332
2. Ghouri N, Purves D, McConnachie A, Wilson J, Gill JM, Sattar N, Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-Aged South Asian compared with European men living in the UK. Diabetologia 2013 56 2238 2249. doi: 10.1007/s00125-013-2969-y.
3. Gomez D, Owens GK, Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012 95 156 164. doi: 10.1093/cvr/cvs115
4. Alexander MR, Owens GK, Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012 74 13 40. doi: 10.1146/annurev-physiol-012110-142315
5. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F, Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005 115 2811 2821. doi: 10.1172/JCI24838
6. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK, Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000 102 1697 1702
7. Dardik A, Yamashita A, Aziz F, Asada H, Sumpio BE, Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg 2005 41 321 331. doi: 10.1016/j.jvs.2004.11.016
8. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R, Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991 253 1129 1132
9. Guan S, Tang Q, Liu W, Zhu R, Li B, Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model. Drug Dev Res 2014 75 489 496. doi: 10.1002/ddr.21230
10. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC, Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 2011 31 e35 e44. doi: 10.1161/ATVBAHA.111.225623
11. Elgar G, Vavouri T, Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet 2008 24 344 352. doi: 10.1016/j.tig.2008.04.005
12. Salic K, De Windt LJ, MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep 2012 14 193 200. doi: 10.1007/s11883-012-0238-z.
13. Jiang Y, Wang HY, Li Y, Guo SH, Zhang L, Cai JH, Cao HM, Wang CY, Wang H, Liu L, Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep 2014 4 5026. doi: 10.1038/srep05026
14. Jiang Y, Wang HY, Cao HM, Wang CY, Zhang L, Wang H, Liu L, Li Y, Cai JH, Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep 2014 4
15. Kaushik K, Leonard VE, Kv S, Lalwani MK, Jalali S, Patowary A, Joshi A, Scaria V, Sivasubbu S, Dynamic expression of long non-coding RNAs (lncRNAs) in adult zebrafish. PLoS One 2013 8 e83616
16. Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q, Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 2014 5 e1506. doi: 10.1038/cddis.2014.466
17. Bell RD, Long X, Lin M, Bergmann JH, Nanda V, Cowan SL, Zhou Q, Han Y, Spector DL, Zheng D, Miano JM, Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol 2014 34 1249 1259. doi: 10.1161/ATVBAHA.114.303240
18. Jaffe EA, Nachman RL, Becker CG, Minick CR, Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973 52 2745 2756. doi: 10.1172/JCI107470
19. Southgate KM, Davies M, Booth RF, Newby AC, Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 1992 288(pt 1) 93 99
20. Dodt M, Roehr JT, Ahmed R, Dieterich C, FLEXBAR-flexible barcode and adapter processing for next-generation sequencing platforms. Biology (Basel) 2012 1 895 905. doi: 10.3390/biology1030895
21. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013 14 R36. doi: 10.1186/gb-2013-14-4-r36
22. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, Van Baren MJ, Salzberg SL, Wold BJ, Pachter L, Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010 28 511 515. doi: 10.1038/nbt.1621
23. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L, Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 2013 31 46 53. doi: 10.1038/nbt.2450
24. Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 402 408. doi: 10.1006/meth.2001.1262
25. Billings FTt, Balaguer JM, C Y, Wright P, Petracek MR, Byrne JG, Brown NJ, Pretorius M, Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass. Clin Pharmacol Ther 2012 91 1065 1073
26. Glynn CL, Khan S, Kerin MJ, Dwyer RM, Isolation of secreted microRNAs (miRNAs) from cell-conditioned media. Microrna 2013 2 14 19
27. Morley-Smith AC, Mills A, Jacobs S, Meyns B, Rega F, Simon AR, Pepper JR, Lyon AR, Thum T, Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail 2014 16 871 879. doi: 10.1002/ejhf.116
28. Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride M, McClure JD, Grant J, Thomas M, Frid M, Stenmark K, White K, Seto AG, Morrell NW, Bradshaw AC, MacLean MR, Baker AH, MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res 2015 117 870 883. doi: 10.1161/CIRCRESAHA.115.306806
29. Soifer HS, Rossi JJ, Saetrom P, MicroRNAs in disease and potential therapeutic applications. Mol Ther 2007 15 2070 2079. doi: 10.1038/sj.mt.6300311
30. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA, Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006 441 537 541. doi: 10.1038/nature04791
31. Karpala AJ, Doran TJ, Bean AG, Immune responses to dsRNA: implications for gene silencing technologies. Immunol Cell Biol 2005 83 211 216. doi: 10.1111/j.1440-1711.2005.01331.x.
32. Wang KC, Chang HY, Molecular mechanisms of long noncoding RNAs. Mol Cell 2011 43 904 914. doi: 10.1016/j.molcel.2011.08.018
33. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnström P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL, Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002 105 2708 2711
34. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, Yeoh SE, Wallace W, Salter D, Fletcher AM, Van Beek EJ, Flapan AD, Uren NG, Behan MW, Cruden NL, Mills NL, Fox KA, Rudd JH, Dweck MR, Newby DE, 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014 383 705 713. doi: 10.1016/S0140-6736(13)61754-7
35. Vesey AT, Irkle A, Lewis DY, Skepper JN, Bird JLE, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR, Brindle KM, Newby DE, Rudd JH, Davenport AP, YY Identifying active vascular microcalcification by F-18-Sodium fluoride positron emission tomography. Brit J Surg 2015 102 5 5
36. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M, Karhunen PJ, Laaksonen R, Lehtimäki T, miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011 219 211 217. doi: 10.1016/j.atherosclerosis.2011.07.020
37. Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y, Wang X, Xu M, Luo GZ, Zhu Y, Xu Q, Wang X, Kong W, Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 2012 32 2580 2588. doi: 10.1161/ATVBAHA.112.300206
38. Cui RR, Li SJ, Liu LJ, Yi L, Liang QH, Zhu X, Liu GY, Liu Y, Wu SS, Liao XB, Yuan LQ, Mao DA, Liao EY, MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res 2012 96 320 329. doi: 10.1093/cvr/cvs258
39. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G, The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009 16 1590 1598. doi: 10.1038/cdd.2009.153
40. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008 5 621 628. doi: 10.1038/nmeth.1226
41. Papakonstantinou E, Roth M, Block LH, Mirtsou-Fidani V, Argiriadis P, Karakiulakis G, The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis 1998 138 79 89
42. Riessen R, Wight TN, Pastore C, Henley C, Isner JM, Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996 93 1141 1147
43. Papakonstantinou E, Karakiulakis G, Roth M, Block LH, Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci U S A 1995 92 9881 9885
44. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, Yamaguchi Y, Rasmussen LM, Wogensen L, Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 2005 96 583 591. doi: 10.1161/01.RES.0000158963.37132.8b.
45. Kashima Y, Takahashi M, Shiba Y, Itano N, Izawa A, Koyama J, Nakayama J, Taniguchi S, Kimata K, Ikeda U, Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One 2013 8 e58760. doi: 10.1371/journal.pone.0058760
46. Van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, Grabitz K, Levkau B, Schrör K, Fischer JW, Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res 2006 98 36 44. doi: 10.1161/01.RES.0000199263.67107.c0
47. Geisler S, Coller J, RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 2013 14 699 712. doi: 10.1038/nrm3679
48. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY, Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007 129 1311 1323. doi: 10.1016/j.cell.2007.05.022
49. Vigetti D, Deleonibus S, Moretto P, Bowen T, Fischer JW, Grandoch M, Oberhuber A, Love DC, Hanover JA, Cinquetti R, Karousou E, Viola M, D'Angelo ML, Hascall VC, De Luca G, Passi A, Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem 2014 289 28816 28826. doi: 10.1074/jbc.M114.597401
50. Taganov KD, Boldin MP, Chang KJ, Baltimore D, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006 103 12481 12486. doi: 10.1073/pnas.0605298103
51. Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y, Wang X, Xu M, Luo GZ, Zhu Y, Xu Q, Wang X, Kong W, Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 2012 32 2580 2588. doi: 10.1161/ATVBAHA.112.300206
52. Johnson JL, Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 2007 5 265 282. doi: 10.1586/14779072.5.2.265
53. Lemesle G, Maluenda G, Collins SD, Waksman R, Drug-eluting stents: issues of late stent thrombosis. Cardiol Clin 2010 28 97 105. doi: 10.1016/j.ccl.2009.09.003
54. Pinel K, Lacoste J, Plane G, Ventura M, Couillaud F, Long-Term in vivo imaging of translated RNAs for gene therapy. Gene Ther 2014 21 434 439. doi: 10.1038/gt.2013.89
55. Vance KW, Sansom SN, Lee S, Chalei V, Kong L, Cooper SE, Oliver PL, Ponting CP, The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J 2014 33 296 311. doi: 10.1002/embj.201386225
56. Climent M, Quintavalle M, Miragoli M, Chen J, Condorelli G, Elia L, TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ Res 2015 116 1753 1764. doi: 10.1161/CIRCRESAHA.116.305178
57. He M, Gong Y, Shi J, Pan Z, Zou H, Sun D, Tu X, Tan X, Li J, Li W, Liu B, Xue J, Sheng L, Xiu C, Yang N, Xue H, Ding X, Yu C, Li Y, Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis. PLoS One 2014 9 e112043. doi: 10.1371/journal.pone.0112043
58. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010 464 1067 1070. doi: 10.1038/nature08956
59. Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Califf RM, Kouchoukos NT, Peterson ED, Alexander JH, Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation 2014 130 1445 1451. doi: 10.1161/CIRCULATIONAHA.113.008193